How Toxic Is Walgreens, Rite Aid Deal for CVS?

Bloomberg Intelligence's Jonathan Palmer reports on the impact of a possible Walgreens and Rite Aid deal on competitor CVS. He speaks on "Bloomberg Markets." (Source: Bloomberg)

Full Show: Surveillance (08/21)
58:29 - Bloomberg Surveillance hosted by Francine Lacqua and David Gura. Guests include James Bevan of CCLA Investment Management , Nathan Sheets of PGIM, and Soren Skou of AP Moller-Maersk A/S. (Source: Bloomberg)
  • Full Show: Surveillance (08/22)
  • Full Show: Bloomberg Daybreak: Americas (08/21)
  • Scholes on Draghi’s Defense of Quantitative Easing